abstract |
Described herein are methods of detecting and treating coronary artery disease and atherosclerotic conditions based on modulating the levels of total and HDL cholesterol in plasma. Also disclosed herein are methods for identifying agents useful for the treatment of coronary artery disease or atherosclerotic conditions. |